MedLife S.A.

MedLife S.A.

About MedLife S.A.

MedLife is the largest private healthcare provider in Romania. The company operates the widest network of clinics, one of the large networks of medical laboratories, general and specialised hospitals and it has the largest client database for Healthcare Prevention Packages in the country. In addition, from the standpoint of sales, it is one of the largest private healthcare companies in Central and Eastern Europe, according to the public information available to MedLife Group.

The shares issued by MedLife SA are traded on the spot regulated market managed by the Bucharest Stock Exchange, Premium Category, with the “M” trading symbol.

President: MARCU MIHAIL

Shareholder structure

Shareholder Shares Percent
CRISTESCU MIHAELA GABRIELA 3,013,800 15.00%
MARCU NICOLAE 3,013,800 15.00%
MARCU MIHAIL 4,219,320 21.00%
alti actionari / others 9,845,080 49.00%
Total 20,092,000 100%

Info provided by: DEPOZITARUL CENTRAL Date: -

Market statistics

  • Today
  • 1 Week
  • 1 Month
  • 6 Month
  • 1 Year
Volume

MedLife acquires 100% stake in Micromedica Medical Center

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNorma ...

Report according art. 82 Law 24/2017 - September 2019

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

MedLife announces the acquisition of 100% shares of Lotus Hospital in Ploiesti

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {margin:0in; margin-bottom:.0001pt; font-size:1 ...

Report according art. 82 Law 24/2017 - August 2019

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

MedLife increases its syndicated loan facilities by EUR 24 million

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 ...

MedLife acquires the majority stake in Onco Team Diagnostic

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNorma ...

Report according art. 82 Law 24/2017 - July 2019

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

Investors and analysts conf-call - H1 2019

Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations   Report Date: 13 August 2019 Name of the issuing company:: MED LIFE S.A. Registered Office: Bucharest, Calea Grivitei, no. 365, d ...

Communique H1 2019 financial results

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {margin:0in; margin-bottom:.0001pt; font-size:12.0 ...

Half-year financial results H1 2019

To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations   Report Date: 13 August 2019 Name of the issuing c ...

Half-year financial results H1 2019

To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and mar ...

Communique Q1 2019 financial results

  MedLife ended Q1 with an increase of 27.6% compared to prior year and announces the continuation of the acquisition program in Romania and the region   May 15, 2019, Bucharest: MedLife, ...

2019 Q1 Report

  To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial in ...

2018 Annual report

In accordance with Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations   Report Date: 23 Ap ...

Preliminary financial results 2018 - Amendment to Romanian version of the Report

   

Preliminary financial results 2018

  To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Current report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of finan ...

Announcement Financial Results Q3 2018

MedLife announces Pro-forma Sales of 606.16 m RON for the first 9 months of this year, up by 32% as compared to 2017 There are indicators that by the end of 2019 Medlife will become the first medi ...

2018 Q3 report

  To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Current report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of finan ...

Communique - Half-year financial results 2018

  MedLife completed H1 2018 with Sales of RON 400 million, up by 33% as compared to H1 2017   Bucharest, August 9, 2018: MedLife, the leader of the Romanian private medical services marke ...

H1 2018 report

No. 31/9.08.2018 CURRENT REPORT Current report drafted according to the stipulations of Rule no. 1/2006 and Law no. 24/2017   Report Date: 9 August 2018 Name of the issuing company ...

Annual financial information

2016
Total Revenues 364,353,536
Total Financial Income 18,697,252
Operating Income 345,656,288
Interest Income 390,842
Total assets 248,107,264
Inventories 6,399,887
Profit for the year -7,752,853
Financial Results -13,907,733
Operating Result 6,963,285
Profit before tax -6,944,448
Employees 1,629
Total Capital Assets 160,173,504
Total Current Liabilities 95,597,952
Shortterm Financial Liabilities 11,214,325
Longterm Financial Liabilities 142,653,680
Trade Payables 64,852,628
Total Longterm Liabilities 159,206,400
Total Receivables 55,703,824
Sales 341,731,552
Total Expenses 371,297,984
Interest expense 6,501,601
Prepaid Expenses 2,724,058
Total Financial Expenses 32,604,984
Operating expenses 338,692,992
Cash and cash equivalents 13,959,191
Total equity 88,900,856
Subscribed Capital 5,023,000
Amortization 25,052,344
Total Non-current Assets 264,918,256
Net Current Assets / Net Current Liabilities -16,810,992
Total Current Assets 76,062,896
Minority Interest 85,613,408

Financial indicators

Year Financial statements Key financials Ministry of Finance format (excerpt)*
2016 Financial preliminary results 2016 Download -
2016 H1 2016 Download -
2016 Q3 2016 Download -
2015 Annual Report 2015 Download -

ANALYST ESTIMATES

ANALYST REPORT February 15, 2017

MedLife: revenues beat expectations, 4Q EBITDA marred by one-offs

M - MedLife S.A.

February 15, 2017 - One-off IPO and M&A-related costs were reflected negatively in MedLife’s reported 4Q16 results, depressing the closely watched EBITDA margin; however, excluding these costs, on an adjusted or pro forma basis, EBITDA was basically in line with our forecast of RON 19.8m. Strong top-line growth – 36% yoy in 4Q and 29% for FY16 – was, however, a positive surprise and suggests to us that profitability can improve throughout 2017E as the impact of higher 4Q15/1H16 employee costs works through the figures, and synergies on recent acquisitions flow to the bottom line (we note that management is also executing plans so these synergies are shared more fairly with equity holders). Management admits that extracting these economies of scale takes time and, while achieving pre-2016 profitability is a key factor for investors, the 4Q results indicate that targeted earnings can be achieved in the meantime through better-than expected top-line growth Achieving the benefits of scale, together with consolidating the Romanian healthcare market, are the key points of our investments thesis for the company. To date, we can see MedLife working towards these goals, and we remain BUYers of the stock.

ANALYST REPORT February 07, 2017

MedLife. A healthy play on the Romanian consumer

M - MedLife S.A.

February 07, 2017 - MedLife offers a rare opportunity to invest in Romanian consumer demand growth and market consolidation. The Romanian private healthcare market should grow by a 17% CAGR through to 2018E, on our estimates, supported by rising disposable income, low per capita spending by regional standards, and a pervasive mistrust of the public healthcare system. MedLife is an active market consolidator and sees untapped potential in second- and third-tier cities, as well as niche areas, such as dentistry.

ANALYST ESTIMATES

Investor Information

Company Presentation

Previous
Next

IR Presentation

  • Date
  • Documents
Previous
Next